Compounds > selenium
Page last updated: 2024-08-26

selenium and transforming growth factor alpha

selenium has been researched along with transforming growth factor alpha in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brychzy, A; de Paulsen, N; Fournier, MC; Gnarra, JR; Klausner, RD; Lee, S; Pause, A1
Aichler, M; Algül, H; Behne, D; Brielmeier, M; Hölzlwimmer, G; Michalke, B; Quintanilla-Martinez, L; Schmid, RM; Schmidt, J1
Anver, MR; Bobe, G; Carlson, BA; Combs, GF; Gladyshev, VN; Hatfield, DL; Hoffmann, VJ; Merlino, G; Moustafa, ME; Perella, CM; Rogers, K; Schweizer, U; Ward, JM; Zhong, N1

Other Studies

3 other study(ies) available for selenium and transforming growth factor alpha

ArticleYear
Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Feb-13, Volume: 98, Issue:4

    Topics: Adenocarcinoma, Clear Cell; Cell Division; Cell Hypoxia; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation; Genes, Tumor Suppressor; Growth Substances; Humans; Insulin; Kidney Neoplasms; Ligases; Oligodeoxyribonucleotides, Antisense; Proteins; Quinazolines; Selenium; Transferrin; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrphostins; Ubiquitin-Protein Ligases; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein

2001
Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-alpha p53+/ mice.
    Carcinogenesis, 2007, Volume: 28, Issue:9

    Topics: Adenocarcinoma; Animals; Dietary Supplements; Elongin; Incidence; Mice; Mice, Inbred BALB C; Mice, Knockout; Pancreatic Neoplasms; Selenium; Transcription Factors; Transforming Growth Factor alpha; Tumor Suppressor Protein p53

2007
Selenium and selenoprotein deficiencies induce widespread pyogranuloma formation in mice, while high levels of dietary selenium decrease liver tumor size driven by TGFα.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Animals; Cell Transformation, Neoplastic; Dietary Supplements; Granuloma; Isotopes; Liver; Liver Neoplasms; Mice; Mice, Transgenic; Organ Specificity; Protein Isoforms; RNA, Transfer, Amino Acid-Specific; Selenium; Selenoproteins; Transforming Growth Factor alpha

2013